Concepts (131)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 14 | 2017 | 111 | 3.480 |
Why?
|
| Tissue Donors | 8 | 2017 | 167 | 2.380 |
Why?
|
| Kidney Transplantation | 9 | 2019 | 352 | 2.200 |
Why?
|
| Kidney Failure, Chronic | 5 | 2017 | 518 | 1.040 |
Why?
|
| Tissue and Organ Procurement | 5 | 2017 | 69 | 0.940 |
Why?
|
| Graft Survival | 5 | 2019 | 228 | 0.860 |
Why?
|
| Donor Selection | 2 | 2019 | 31 | 0.760 |
Why?
|
| Waiting Lists | 3 | 2017 | 30 | 0.670 |
Why?
|
| Brain Death | 3 | 2012 | 27 | 0.620 |
Why?
|
| Poverty | 1 | 2018 | 99 | 0.600 |
Why?
|
| Bile Duct Diseases | 3 | 2011 | 9 | 0.550 |
Why?
|
| Registries | 3 | 2017 | 278 | 0.520 |
Why?
|
| Death | 2 | 2012 | 41 | 0.510 |
Why?
|
| Liver Diseases | 2 | 2013 | 61 | 0.500 |
Why?
|
| Comparative Effectiveness Research | 2 | 2014 | 23 | 0.480 |
Why?
|
| Models, Statistical | 1 | 2012 | 163 | 0.400 |
Why?
|
| Retrospective Studies | 9 | 2019 | 3112 | 0.390 |
Why?
|
| Renal Dialysis | 4 | 2017 | 260 | 0.390 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2011 | 59 | 0.380 |
Why?
|
| United States | 7 | 2017 | 3632 | 0.370 |
Why?
|
| Heart Arrest | 1 | 2010 | 39 | 0.360 |
Why?
|
| Risk Factors | 7 | 2017 | 3537 | 0.350 |
Why?
|
| Middle Aged | 12 | 2019 | 10834 | 0.350 |
Why?
|
| Humans | 22 | 2019 | 29123 | 0.340 |
Why?
|
| Health Care Costs | 1 | 2010 | 108 | 0.340 |
Why?
|
| Quality of Life | 2 | 2016 | 816 | 0.330 |
Why?
|
| Living Donors | 3 | 2016 | 54 | 0.320 |
Why?
|
| Postoperative Complications | 4 | 2017 | 670 | 0.300 |
Why?
|
| Proportional Hazards Models | 3 | 2017 | 709 | 0.280 |
Why?
|
| Male | 14 | 2019 | 17815 | 0.280 |
Why?
|
| Adult | 11 | 2019 | 8426 | 0.270 |
Why?
|
| Treatment Outcome | 7 | 2017 | 3101 | 0.240 |
Why?
|
| Female | 12 | 2019 | 18173 | 0.240 |
Why?
|
| Cost-Benefit Analysis | 2 | 2013 | 159 | 0.210 |
Why?
|
| Risk Assessment | 4 | 2017 | 1306 | 0.210 |
Why?
|
| Ischemia | 2 | 2011 | 92 | 0.180 |
Why?
|
| Age Factors | 3 | 2019 | 1108 | 0.180 |
Why?
|
| Survival Analysis | 4 | 2019 | 440 | 0.170 |
Why?
|
| Markov Chains | 3 | 2015 | 25 | 0.170 |
Why?
|
| Aged | 5 | 2019 | 9492 | 0.160 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2017 | 29 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2015 | 207 | 0.150 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 55 | 0.150 |
Why?
|
| Nephrology | 1 | 2017 | 34 | 0.150 |
Why?
|
| Transplantation, Homologous | 1 | 2017 | 113 | 0.150 |
Why?
|
| Time Factors | 3 | 2017 | 2001 | 0.150 |
Why?
|
| Kidney Function Tests | 1 | 2017 | 102 | 0.150 |
Why?
|
| Chi-Square Distribution | 1 | 2017 | 293 | 0.140 |
Why?
|
| Continental Population Groups | 1 | 2018 | 221 | 0.140 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 287 | 0.140 |
Why?
|
| Minority Groups | 1 | 2016 | 69 | 0.140 |
Why?
|
| Healthcare Disparities | 1 | 2018 | 153 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 637 | 0.130 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 2109 | 0.130 |
Why?
|
| Ethnic Groups | 1 | 2018 | 440 | 0.130 |
Why?
|
| Policy Making | 1 | 2015 | 19 | 0.130 |
Why?
|
| Diabetes Complications | 1 | 2016 | 171 | 0.130 |
Why?
|
| Medicare | 1 | 2016 | 186 | 0.130 |
Why?
|
| Prognosis | 2 | 2017 | 1362 | 0.120 |
Why?
|
| Models, Theoretical | 1 | 2015 | 126 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 360 | 0.120 |
Why?
|
| Young Adult | 2 | 2019 | 2402 | 0.110 |
Why?
|
| Health Resources | 2 | 2010 | 33 | 0.110 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 23 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2016 | 413 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 231 | 0.110 |
Why?
|
| Decision Trees | 1 | 2012 | 23 | 0.110 |
Why?
|
| Kidney Diseases | 1 | 2014 | 239 | 0.100 |
Why?
|
| Informed Consent | 1 | 2011 | 51 | 0.100 |
Why?
|
| Primary Graft Dysfunction | 1 | 2011 | 1 | 0.100 |
Why?
|
| Biliary Tract Diseases | 1 | 2011 | 8 | 0.100 |
Why?
|
| Heart Failure | 1 | 2016 | 571 | 0.100 |
Why?
|
| Renal Veins | 1 | 2010 | 5 | 0.100 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2010 | 12 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2011 | 60 | 0.100 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 53 | 0.100 |
Why?
|
| Patient Selection | 1 | 2012 | 257 | 0.090 |
Why?
|
| Hepatitis C, Chronic | 1 | 2011 | 77 | 0.090 |
Why?
|
| Age Distribution | 1 | 2011 | 198 | 0.090 |
Why?
|
| Reoperation | 1 | 2011 | 203 | 0.090 |
Why?
|
| Cause of Death | 1 | 2011 | 220 | 0.090 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 35 | 0.090 |
Why?
|
| Hospital Costs | 1 | 2010 | 36 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2011 | 149 | 0.090 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 162 | 0.090 |
Why?
|
| Hepatectomy | 1 | 2009 | 66 | 0.090 |
Why?
|
| Health Status Indicators | 1 | 2009 | 67 | 0.090 |
Why?
|
| Psychometrics | 1 | 2009 | 129 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2009 | 169 | 0.080 |
Why?
|
| Liver | 1 | 2010 | 464 | 0.080 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2006 | 1 | 0.070 |
Why?
|
| Biliary Atresia | 1 | 2006 | 2 | 0.070 |
Why?
|
| Ileus | 1 | 2005 | 5 | 0.070 |
Why?
|
| Pneumothorax | 1 | 2005 | 8 | 0.070 |
Why?
|
| Neuroblastoma | 1 | 2006 | 32 | 0.070 |
Why?
|
| Intestinal Diseases | 1 | 2005 | 18 | 0.070 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 23 | 0.070 |
Why?
|
| Peptides | 1 | 2006 | 118 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 148 | 0.060 |
Why?
|
| Infant | 3 | 2019 | 969 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2019 | 1167 | 0.050 |
Why?
|
| Child | 2 | 2019 | 2219 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2017 | 175 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2017 | 124 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2016 | 136 | 0.030 |
Why?
|
| Adolescent | 2 | 2019 | 3255 | 0.030 |
Why?
|
| Comorbidity | 1 | 2016 | 540 | 0.030 |
Why?
|
| Logistic Models | 1 | 2016 | 727 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2006 | 599 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 726 | 0.030 |
Why?
|
| Empirical Research | 1 | 2011 | 8 | 0.030 |
Why?
|
| Mesenteric Veins | 1 | 2010 | 5 | 0.020 |
Why?
|
| Liver Circulation | 1 | 2010 | 5 | 0.020 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2010 | 4 | 0.020 |
Why?
|
| Portal Vein | 1 | 2010 | 16 | 0.020 |
Why?
|
| Iliac Vein | 1 | 2010 | 8 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2010 | 25 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 82 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2009 | 23 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2011 | 251 | 0.020 |
Why?
|
| Decision Making | 1 | 2011 | 180 | 0.020 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2009 | 31 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2009 | 865 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2006 | 11 | 0.020 |
Why?
|
| Meconium | 1 | 2005 | 2 | 0.020 |
Why?
|
| Intussusception | 1 | 2005 | 2 | 0.020 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 12 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2006 | 158 | 0.020 |
Why?
|
| Abdomen | 1 | 2005 | 42 | 0.020 |
Why?
|
| Proteomics | 1 | 2006 | 92 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2006 | 223 | 0.020 |
Why?
|